Dermata Therapeutics, Inc. Common Stock (DRMA)
Dermata Therapeutics, Inc. (DRMA) is a dermatology-focused biotech company dedicated to developing innovative treatments for skin conditions. The company leverages its expertise in dermatological sciences to create targeted therapies aimed at improving patient outcomes in various skin disorders.
Company News
Enphase Energy reported mixed Q2 results, leading to a rise in its stock price. Several other companies saw significant pre-market movements, both positive and negative, due to various news and earnings reports.
Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2024 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Dermata (DRMA) announces reaching an agreement with the FDA to begin a late-stage pivotal clinical program for its acne treatment candidate, DMT310. The stock rises 7%.